Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Cytokine storm in COVID-19: the current evidence and treatment strategies
Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is the pathogen that causes
coronavirus disease 2019 (COVID-19). As of 25 May 2020, the outbreak of COVID-19 has …
coronavirus disease 2019 (COVID-19). As of 25 May 2020, the outbreak of COVID-19 has …
Immune-mediated inflammatory disease therapeutics: past, present and future
Immune-mediated inflammatory diseases are common and clinically diverse. Although they
are currently incurable, the therapeutic armamentarium for immune-mediated inflammatory …
are currently incurable, the therapeutic armamentarium for immune-mediated inflammatory …
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
Objectives To update the Assessment of SpondyloArthritis international Society (ASAS)-
EULAR recommendations for the management of axial spondyloarthritis (axSpA). Methods …
EULAR recommendations for the management of axial spondyloarthritis (axSpA). Methods …
ECCO guidelines on inflammatory bowel disease and malignancies
This guideline is the second European Crohn's and Colitis Organisation [ECCO] evidence-
based consensus on inflammatory bowel disease [IBD] and malignancy, and is an update …
based consensus on inflammatory bowel disease [IBD] and malignancy, and is an update …
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Objective To develop evidence-based European Alliance of Associations for Rheumatology
(EULAR) points to consider (PtCs) for the management of difficult-to-treat rheumatoid …
(EULAR) points to consider (PtCs) for the management of difficult-to-treat rheumatoid …
COVID-19 infection and rheumatoid arthritis: Faraway, so close!
The outbreak of the new coronavirus infections COVID-19 in December 2019 in China has
quickly become a global health emergency. Given the lack of specific anti-viral therapies, the …
quickly become a global health emergency. Given the lack of specific anti-viral therapies, the …
Role of inflammatory cytokines in COVID-19 patients: a review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to …
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …
Disease-modifying anti-asthmatic drugs
Drugs available for asthma treatment in the first decades of the 20th century
(sympathomimetic agents such as oral ephedrine, intravenous adrenaline, or inhaled …
(sympathomimetic agents such as oral ephedrine, intravenous adrenaline, or inhaled …
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad
The pathogenesis of Coronavirus disease 2019 (COVID-19) is gradually being
comprehended. A high number of thrombotic episodes are reported, along with the mortality …
comprehended. A high number of thrombotic episodes are reported, along with the mortality …
[HTML][HTML] Targeting JAK-STAT signaling to control cytokine release syndrome in COVID-19
Recent advances in the pathophysiologic understanding of the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection has indicated that patients with severe …
syndrome coronavirus 2 (SARS-CoV-2) infection has indicated that patients with severe …